DPP4 and pulmonary fibrosis: Simultaneously, a mouse model of LPS-induced pulmonary fibrosis was used to demonstrate in vivo that combined treatment with miR-23b-3p and DPP4 inhibitors can greatly alleviate pulmonary fibrosis in mice.